Feng Chai

Phase I Trial of a Selective c-MET Inhibitor ARQ 197 Incorporating Proof of Mechanism Pharmacodynamic Studies

Timothy A. Yap, David Olmos, André T. Brunetto et al. · Journal of Clinical Oncology · 2011 · 195 citations · Full text

Medicine, Oncology, Pharmacology +16

Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor–associated tumors

Andrew J. Wagner, John M. Goldberg, Steven G. DuBois et al. · Cancer · 2012 · 155 citations

Medicine, Oncology, Pharmacology +16

Prolonged local antibiotics delivery from hydroxyapatite functionalised with cyclodextrin polymers

Stéphane Leprêtre, Feng Chai, Jean‐Christophe Hornez et al. · Biomaterials · 2009 · 114 citations

Pharmacy, Biomedical Engineering, Pharmaceutics +14

Phenolic Compounds from Humulus lupulus as Natural Antimicrobial Products: New Weapons in the Fight against Methicillin Resistant Staphylococcus aureus, Leishmania mexicana and Trypanosoma brucei Strains

Laetitia Bocquet, Sevser Şahpaz, Natacha Bonneau et al. · Molecules · 2019 · 100 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +12

Bioinspired Titanium Drug Eluting Platforms Based on a Poly-β-cyclodextrin–Chitosan Layer-by-Layer Self-Assembly Targeting Infections

Alexandra Perez‐Anes, Myriem Gargouri, William Laure et al. · ACS Applied Materials & Interfaces · 2015 · 77 citations · Full text

Natural Sciences, Bioengineering, Biomedical Engineering +17